Citadel Advisors
PHAT icon

Citadel Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History

Citadel Advisors’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
19,200
-10,400
-35% -$131K ﹤0.01% 11294
2025
Q4 		$491K Buy
+29,600
New +$423K ﹤0.01% 9064
2025
Q3 		– Sell
-62,000
Closed -$595K – 13775
2025
Q2 		$595K Buy
62,000
+25,300
+69% +$140K ﹤0.01% 8228
2025
Q1 		$230K Sell
36,700
-52,700
-59% -$320K ﹤0.01% 10171
2024
Q4 		$726K Buy
89,400
+77,000
+621% +$954K ﹤0.01% 7735
2024
Q3 		$224K Buy
12,400
+7,700
+164% +$108K ﹤0.01% 9915
2024
Q2 		$48.4K Sell
4,700
-4,300
-48% -$44.3K ﹤0.01% 11793
2024
Q1 		$95.6K Buy
9,000
+2,200
+32% +$18.7K ﹤0.01% 11426
2023
Q4 		$62.1K Buy
6,800
+4,000
+143% +$34.5K ﹤0.01% 11551
2023
Q3 		$29K Sell
2,800
-2,500
-47% -$34.3K ﹤0.01% 12296
2023
Q2 		$75.9K Buy
5,300
+3,400
+179% +$39.2K ﹤0.01% 11300
2023
Q1 		$13.6K Sell
1,900
-8,600
-82% -$75.5K ﹤0.01% 13356
2022
Q4 		$118K Buy
+10,500
New +$108K ﹤0.01% 10993

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return